Seller record · geopeptides.com

Geo Peptides

Recorded September 2026 · Standard v1.1

Fails 5 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any of the five pages read, and a footer notice sells every product for research and development only. 4 more criteria also fail; see the table below.

Research vendor. Passes 3 of 8 criteria. Recorded against Standard v1.1.

A research peptide and chemical seller offering GLP-1 analogues, SARMs and bulk compounds. Its homepage advertises third-party testing and certificates, and no certificate is reachable from any page read.

Operating entity The footer, the about page, the terms and conditions and the privacy policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	geopeptides.com/terms-conditions
S2	Prescription gating	FAIL	geopeptides.com/checkout
S3	Pharmacy identification	FAIL	geopeptides.com/about-us
S4	Compounding disclosure	PASS	geopeptides.com/about-us
S5	Analytical documentation	FAIL	geopeptides.com
S6	Business address	FAIL	geopeptides.com/about-us
S7	Price disclosure	PASS	geopeptides.com
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any of the five pages read, and a footer notice sells every product for research and development only.Source: geopeptides.com/terms-conditions.

S2FAILThe order path was walked from the tirzepatide page at 249.99 dollars to a guest checkout collecting a shipping address, which states that an account may be created after checkout.Source: geopeptides.com/checkout.

S3FAILNo pharmacy is named on any of the five pages read, and a footer notice states that the seller is not a compounding pharmacy under section 503A.Source: geopeptides.com/about-us.

S4PASSThe seller offers no compounded drug, and a footer notice on every page read states that the products have not been evaluated by the Food and Drug Administration.Source: geopeptides.com/about-us.

S5FAILThe homepage offers to show third-party analytical testing and certificates for selected products, and no certificate file is reachable from that heading or from any of the five pages read.Source: geopeptides.com.

S6FAILThe five pages read, covering footer, about, questions, terms and privacy, print an email address and shipping guidance and no street address anywhere.Source: geopeptides.com/about-us.

S7PASSThe tirzepatide page prints 249.99 dollars and 299.99 dollars across two sizes with no account required, and the catalog prints figures from 29.99 dollars upward.Source: geopeptides.com.

S8PASSNo letter names the storefront in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including tirzepatide and GLP-2, SARMs, bulk chemicals and peptides, research liquids.

Sellers passing S1, prescriber requirement

Records dated September 2026

Records dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.